Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy
Renal cell carcinoma, particularly the most common clear cell type, is one of the most aggressive of urological cancers with significant risk of metastatic spread. It also has a propensity for venotropism with a proportion of tumors developing thrombi up to the right atrium. The response with newly...
Saved in:
Main Authors: | Abhishek Bhat, Bruno Nahar, Vivek Venkatramani, Indraneel Banerjee, Oleksandr N. Kryvenko, Dipen J. Parekh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Urology |
Online Access: | http://dx.doi.org/10.1155/2019/7102504 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma
by: Taylor C. Peak, et al.
Published: (2020-01-01) -
Locoregional treatments of metastatic internal mammary node following neoadjuvant chemotherapy
by: Jinhui Zhang, et al.
Published: (2025-02-01) -
Efficacy and safety of neoadjuvant therapy with tislelizumab plus axitinib for nonmetastatic renal cell carcinoma with inferior vena cava tumor thrombus: a retrospective study
by: Zhongjie Zhao, et al.
Published: (2025-01-01) -
Cytoreductive Nephrectomy and Nephrectomy/Complete Metastasectomy for Metastatic Renal Cancer
by: Paul Russo, et al.
Published: (2007-01-01) -
Contemporary studies in conversation analysis vol. IV. : institutions and applications /
Published: (2013)